New startup ideas · Health and bio · Healthcare and bio

startup idea

Kelvin Bench

A $18,000 benchtop robot that runs any wet-lab protocol written in plain English.

Kelvin Bench is a benchtop liquid-handling and imaging robot sold outright to small labs: a two-person biotech, a university group, a contract formulation shop.

Hardware
Small business
$1-10B market
Platform others build on
Global from day one

3/5

venture judge

similar startups, last 2 years (1 all-time)

97%

of 4 nearest real companies still alive

yes

1 matching federal grants and programs

Direction supported by government programs and grants

Test it before you build it

$1,700 · 4 weeks · 25 prospects

For $1,700 and 4 weeks, prove that seed-stage biotech founders without an automation engineer will put down $1,000 refundable deposits against an $18,000 robot instead of hiring another pair of hands.

Riskiest assumption · A seed-stage biotech founder with no automation engineer will spend $18,000 of seed or grant money on capital equipment to automate serial dilution, rather than defaulting to another pair of human hands that a grant pays for more easily

1Focus group: who and where

The founding scientist of a 2-8 person biotech funded in the last 18 months with no automation engineer, whose team hand-pipettes serial dilutions and plate reads for hours every day and whose runway math makes a $70,000 technician hire painful

where to find 25 · Resident companies at LabCentral in Cambridge and BioLabs sites, where dozens of exactly these teams share benches; the YC Startup Directory filtered to recent biotech batches, which lists names and stages publicly; r/labrats, where bench scientists complain daily about manual serial dilutions

2Sell first, build later

An $18,000 benchtop robot that runs serial dilution and plate imaging from a plain-English protocol, first 10 units shipping March 2027, with the buyer's own protocol compiled and validated before delivery

the ask · $18,000 per unit, one-time; $1,000 refundable reservation now

a real yes · A $1,000 deposit that clears counts; 'we'd definitely buy one when it exists', a request to be a free beta site, and enthusiastic Reddit comments do not

3Small experiments

The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.

1. Founder-to-founder reservation pitch
$1,000 · 21 days
Book 25 demo calls with founders from the LabCentral, BioLabs and YC lists, including a two-day Boston trip to walk shared-lab floors. On each call, run the plain-English protocol compiler live on the prospect's own serial-dilution protocol (text in, machine steps out, no hardware yet) and ask for a $1,000 refundable deposit against a March 2027 unit at $18,000.
keep going if · 6 of 25 calls end with a paid $1,000 reservation
2. Rent-versus-buy framing test
$100 · 14 days
Offer half the prospects who decline the purchase a $1,500 per month rental of the same unit instead, tracked in a simple sheet. This separates 'the robot isn't worth it' from 'my grant pays salaries, not instruments', which is the objection the card predicts.
keep going if · If rental yeses outnumber purchase yeses 3 to 1, the capex model is wrong and pricing must change before any build
3. Priced spec sheet page
$600 · 10 days
Publish a one-page site with the $18,000 price, industrial-design renders, the compiler demo video, and the reservation checkout, then post it to r/labrats and pin flyers at LabCentral. No stealth pricing: the price is the test.
keep going if · 10 demo calls booked from the first 200 unique visitors

4Collect a deposit up front

Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.

$1,000

per prospect, refundable

how · A refundable reservation invoiced by ACH or card after the demo call, with a one-page countersigned reservation agreement naming the serial number and ship month: standard hardware pre-order mechanics for a founder-led sale, sized at about 5% of the purchase price set up: Stripe Invoicing ↗

what it reserves · One of 10 serial numbers in the first build, the $18,000 price locked, and the buyer's serial-dilution and plate-imaging protocol validated on their plate layouts before shipment

refund · Refundable in full at any request before the unit ships, returned within 5 business days

target · 6 paid reservations from 25 demo calls within 30 days

Go: build it if

6 of 25 founders pay $1,000 deposits at the $18,000 price: order long-lead parts and build the first 10

Kill: stop if

2 or fewer deposits from 25 calls, with most declines citing grant and budget rules that fund salaries but not instruments: stop, or restart as a rental or per-run service, which is a different company

5 Scripts to run itoutreach message, landing copy, deposit terms · click to open

outreach message

You just raised a seed round and someone on your two-person team is hand-pipetting serial dilutions for hours every day. I'm building Kelvin Bench, an $18,000 benchtop robot that runs protocols written in plain English, starting with serial dilution plus plate imaging, first 10 units shipping March 2027. A $1,000 refundable deposit reserves a unit and gets your protocol validated before delivery. Can I take 20 minutes this week to run the compiler on one of your actual protocols?

landing page

An $18,000 benchtop robot that runs protocols written in plain English $1,000 refundable deposit reserves a March 2027 unit at a locked $18,000, with your serial-dilution protocol validated before shipment Reserve one of 10 first-build slots

deposit terms

A $1,000 deposit reserves one of 10 serial numbers in the first build, shipping March 2027, and locks your price at $18,000. Before shipment we compile and validate your serial-dilution and plate-imaging protocol on your plate layouts. The deposit is refundable in full at any request before your unit ships, returned within 5 business days.

Would you run this test?

One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.

Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.

Scorecard

One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.

Idea Score, 0-100 · raw 45.7 x 1.61

Warm

competition: more crowded than 20% of ideas · headwind x0.90

+0.8

government priorities, secondary (1 matching grants)

Trend

Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.

Entrants 2025-26 vs 2023-24 (similar companies)70
Rounds announced 2025+ in the sector69
Sector direction (live batch)100
2026 trend analyst75

Demand

Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.

YC asks for it (current RFS: idea / sector)30
Someone already pays (similar companies, recent / all-time)17
Operator judge: real pain25

100x potential

Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.

Venture judge50
Market size axis33
Moat axis100
Technologist judge100

Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were 000, benchtop, robot, wet-lab, protocol, written, kelvin, bench.

The idea in full

What: Kelvin Bench is a benchtop liquid-handling and imaging robot sold outright to small labs: a two-person biotech, a university group, a contract formulation shop. Protocols are written as text, compiled to machine steps, and every run streams back plate images, timings and outcomes, so the device gets better at execution the more runs the fleet does. Third parties publish protocols and hardware modules against an open SDK and take a share of what they sell, which turns the box from a tool into a platform for research-use-only work that needs no regulatory clearance.
Why now: The current cohort is buying exactly this layer: Omanta (yc S26) pitches "A research lab for one", 10x Science (yc W26) is "the AI-native platform for next-generation protein characterization", AbInitio Bio (yc X26) calls itself "the intelligence layer for drug manufacturing", and Rasyn (yc S26) is chasing "a general intelligence for chemistry" - all of them need physical execution they do not want to build, and the cluster added 126 new companies in 2024 alone, most of them too small to buy an automation suite.
Wedge: first customer and entry point: Sell the first 30 units founder-to-founder into recently funded seed-stage biotechs that have no automation engineer, starting with one protocol family (serial dilution plus plate imaging) that is boring, repetitive and eats a full-time hand.
Path to 100x: Small-lab automation is a $1-10B hardware and consumables market, and the winner is decided by the protocol library, not the chassis: once a few thousand validated protocols only run on Kelvin Bench, buying a competing box means rewriting the lab's methods. Every run is telemetry, so the fleet's success-rate data becomes the reason protocol authors publish here first, and authors bring the next buyers.
Ceiling: Small labs may keep buying human hands instead of capital equipment because a grant pays salaries more easily than instruments, holding unit volume in the low thousands and revenue in the low hundreds of millions.
Closest real companies, as the generator saw them: Omanta is building a research lab for one as a service; Kelvin Bench sells the machine and the protocol marketplace instead of the lab. 10x Science and AbInitio Bio provide software intelligence layers that need a physical executor, which is the position Kelvin Bench occupies. Scala Biodesign designs molecules rather than running the bench work.
Main risk: Hardware reliability in unattended overnight runs falls short, and a $18,000 box that fails one run in ten is returned to the shelf where used liquid handlers already sit.

Five judges

Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).

Venture investor
3/5
Protocol library lock-in is real, but the card concedes unit volume in the low thousands and revenue in low hundreds of millions.
Bootstrapper
2/5
An $18,000 box sold founder-to-founder means inventory, warranty and returns capital far beyond a two-person team's float.
Operator
2/5
The card concedes grants fund salaries more easily than instruments, so an $18,000 capex ask fights the buyer's own budget rules.
Technologist
5/5
A plain-English protocol compiler on owned hardware with run telemetry means the validated protocol library gets harder to leave with every run.
Risk
5/5
Research-use-only means no clearance needed, boxes are sold outright to thousands of independent labs globally, and revenue starts within a year with no gatekeeper in between.
trends
4/5
Rides the robotics cluster jumping from 6% to 13% of the batch, with named S26 buyers like Omanta needing physical execution they will not build.

Similar startups in the directory

Companies whose pitch matches most of the idea's terms (000, benchtop, robot, wet-lab, protocol, written, kelvin, bench): 1 all-time, 1 from the last two years. Same matching as Idea Check.

DeepReach Inc.yc S26 · 2026 · Data for AIalive
Network for Physical AI Data Business

Run this as an Idea Check →

The generator's reference companies

Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.

Public money in this direction

US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.

grants and programs matching the idea

1595

startup-relevant grants in Healthcare and bio

$854M

awarded in the sector, tracked

118

opportunities open now in the sector

Restoring Self-Feeding with a Sensor Driven Robotic Systemawardhigh relevance
NIH / NIA · STTR phase I · $307K · posted 2025-09-20

All public money by sector →

Market signal

What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.

Healthcare and bio · 135 → 121 → 224 → 173 → 127 new companies 2022 → 2026 · 91% aliveYC F26 live: 2 in this cluster, 2% of the batch (was 6% in S26)Since February, of 442 YC companies here: 6 acquired, 6 shut down, 45 rewrote their pitch

Healthcare and bio: companies, trend and grants →

Design attributes

The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.

Buyer: Small business
Business model: Hardware
Path to 100x: Platform others build on
Market size: $1-10B market
Capital intensity: Capital-heavy (hardware, bio, infra)
Speed to revenue: Revenue within a year
Technical depth: Real engineering
Go-to-market: Founder-led sales
Moat: Data moat
Geography: Global from day one
Regulation: Unregulated
Vibe: Hot space